AXL and lung carcinoma: In EGFR‐mutant lung cancer, inhibition of IGF‐1R, AXL, FGFR3, YAP‐TEAD, AURKA, Wnt/b‐catenin, and NF‐κB transcription in the DTCs combined EGFR TKI treatment will help eliminate DTCs.44, 74, 116, 220, 233, 237, 238